Please assess the completion status of the following clinical trial:

Trial Title: Wellness Engagement Project, Petersburg

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 18-65 years.~* Must have a school going child between 12-17 living in the home.~* BMI between 25 and 50 kg/m2.~Exclusion Criteria:~* report not being able to walk 2 blocks (1/4 mile) without stopping~* currently participating in another weight loss program~* taking a weight loss medication~* have a history of bariatric surgery~* pregnant or plan to become pregnant during the intervention timeframe~* report an unsupervised heart condition, chest pain during periods of rest or activity, or loss of consciousness on the Physical Activity Readiness Questionnaire~* report a medical condition that would jeopardize their safety if involved in a weight management program with diet and exercise guidelines (e.g., uncontrolled heart problem)~* fail medical screening by study medical staff)~* report conditions that, in the judgment of the PI, would render the participant unlikely to follow the study protocol (e.g., planned move from the area, dementia, substance abuse).

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Intervention-Wellness Engagement Program (Type: EXPERIMENTAL): The group assigned to the intervention arm will receive treatment as described below for a twelve week period:~Weekly lessons related to healthy eating and physical activity Biweekly check-in calls with a trained peer support coach Access to neighborhood wide physical activity and nutritional education events
- Delayed treatment control group (Type: NO_INTERVENTION): The delayed treatment control group will not receive the intervention for measurement purposes; however the intervention as described will be administered to this group upon conclusion of the 12 week period for the intervention group.

Based on this trial design, predict the completion outcome and termination type (if applicable).